Search Results

There are 10772 results for: content related to: Correlation between pretreatment viral sequences and the emergence of lamivudine resistance in hepatitis B virus infection

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. Lamivudine salts with improved solubilities

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 6, June 2012, Pages: 2143–2154, Felipe T. Martins, Rudy Bonfilio, Magali B. De Araújo and Javier Ellena

    Version of Record online : 14 MAR 2012, DOI: 10.1002/jps.23117

  3. Abstract Index

    Journal of Gastroenterology and Hepatology

    Volume 19, Issue s7, December 2004, Pages: A676–A868,

    Version of Record online : 3 DEC 2004, DOI: 10.1111/j.1440-1746.2004.03735.x

  4. Management of viral hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 17, Issue s1, February 2002, Pages: S125–S145, CHUTIMA PRAMOOLSINSUP

    Version of Record online : 8 MAY 2002, DOI: 10.1046/j.1440-1746.17.s1.3.x

  5. Viral Hepatitis

    Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition

    Mario Rizzetto, Fabien Zoulim, Pages: 819–956, 2008

    Published Online : 15 APR 2008, DOI: 10.1002/9780470691861.ch9a

  6. Should lamivudine monotherapy be stopped or continued in patients infected with hepatitis B with favorable responses after more than 5 years of treatment?

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 34–42, Jung Hyun Kwon, Jeong Won Jang, Jong Young Choi, Chung-Hwa Park, Sun Hong Yoo, Si Hyun Bae and Seung Kew Yoon

    Version of Record online : 14 NOV 2012, DOI: 10.1002/jmv.23421

  7. Lamivudine treatment of chronic hepatitis B

    Reviews in Medical Virology

    Volume 8, Issue 3, July/September 1998, Pages: 153–159, Geoffrey Dusheiko

    Version of Record online : 4 MAY 1999, DOI: 10.1002/(SICI)1099-1654(199807/09)8:3<153::AID-RMV228>3.0.CO;2-Y

  8. You have free access to this content
    A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial

    Hepatology

    Volume 47, Issue 3, March 2008, Pages: 844–853, Chiun Hsu, Chao A. Hsiung, Ih-Jen Su, Wei-Shou Hwang, Ming-Chung Wang, Sheng-Fung Lin, Tseng-Hsi Lin, Hui-Hua Hsiao, Ji-Hsiung Young, Ming-Chih Chang, Yu-Min Liao, Chi-Cheng Li, Hung-Bo Wu, Hwei-Fang Tien, Tsu-Yi Chao, Tsang-Wu Liu, Ann-Lii Cheng and Pei-Jer Chen

    Version of Record online : 27 DEC 2007, DOI: 10.1002/hep.22106

  9. Developmental Pharmacokinetic Changes of Lamivudine in Infants and Children

    The Journal of Clinical Pharmacology

    Volume 52, Issue 12, December 2012, Pages: 1824–1832, Dr Adriana H. Tremoulet, Dr Mina Nikanjam, Dr Tim R. Cressey, Dr Kulkanya Chokephaibulkit, Dr Ross McKinney, Dr Mark Mirochnick and Dr Edmund V. Capparelli

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011426563

  10. You have free access to this content
    Chronic hepatitis B

    Hepatology

    Volume 45, Issue 2, February 2007, Pages: 507–539, Anna S. F. Lok and Brian J. McMahon

    Version of Record online : 26 JAN 2007, DOI: 10.1002/hep.21513

  11. Lamivudine/Zidovudine as a Combined Formulation Tablet: Bioequivalence Compared with Lamivudine and Zidovudine Administered Concurrently and the Effect of Food on Absorption

    The Journal of Clinical Pharmacology

    Volume 39, Issue 6, June 1999, Pages: 593–605, Dr. Katy H. P. Moore, Ms. Shuching Shaw, Dr. Aziz L. Laurent, Ms. Peggy Lloyd, Mr. Benjamin Duncan, Mr. David M. Morris, Mr. Michael J. O'Mara and Dr. Gary E. Pakes

    Version of Record online : 8 MAR 2013, DOI: 10.1177/00912709922008209

  12. You have free access to this content
    Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 3, March 2010, Pages: 583–590, Li-Jie Sun, Jian-Wu Yu, Yong-Hua Zhao, Peng Kang and Shu-Chen Li

    Version of Record online : 24 NOV 2009, DOI: 10.1111/j.1440-1746.2009.06089.x

  13. Efficacy of lamivudine re-treatment for relapsed patients after an initial lamivudine therapy in HBeAg-positive chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 12, Issue 4, July 2005, Pages: 393–397, J. W. Shin, N. H. Park, J. H. Park, J. H. Park, I. D. Jeong, S-J. Bang, K. R. Joo and D. H. Kim

    Version of Record online : 14 MAR 2005, DOI: 10.1111/j.1365-2893.2005.00606.x

  14. Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine

    Liver International

    Volume 31, Issue 5, May 2011, Pages: 667–675, Rifaat Safadi, Qing Xie, Yagang Chen, You-Kuan Yin, Lai Wei, Seong Gyu Hwang, Eli Zuckerman, Ji-Dong Jia and Patricia Lopez

    Version of Record online : 29 OCT 2010, DOI: 10.1111/j.1478-3231.2010.02360.x

  15. Chronic Hepatitis B: Current and Future Treatment Options

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 6, June 2002, Pages: 721–737, Anastasia Rivkina and Sergey Rybalov

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.22.9.721.34058

  16. Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma

    Intervention Review

    The Cochrane Library

    Jian Hong Zhong, Le Qun Li and Liu Cheng Wu

    Published Online : 7 DEC 2011, DOI: 10.1002/14651858.CD008713.pub2

  17. You have free access to this content
    A model-based approach for the evaluation of once daily dosing of lamivudine in HIV-infected children

    British Journal of Clinical Pharmacology

    Volume 77, Issue 5, May 2014, Pages: 852–860, Chiara Piana, Wei Zhao, Kimberly Adkison, David Burger, Evelyne Jacqz-Aigrain, Meindert Danhof and Oscar Della Pasqua

    Version of Record online : 22 APR 2014, DOI: 10.1111/bcp.12246

  18. You have free access to this content
    Biowaiver monographs for immediate release solid oral dosage forms: Lamivudine

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 6, June 2011, Pages: 2054–2063, S. Strauch, E. Jantratid, J. B. Dressman, H. E. Junginger, S. Kopp, K. K. Midha, V. P. Shah, S. Stavchansky and D. M. Barends

    Version of Record online : 9 FEB 2011, DOI: 10.1002/jps.22449

  19. Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole

    Clinical Pharmacology & Therapeutics

    Volume 59, Issue 5, May 1996, Pages: 550–558, Katy H. P. Moore, Geoffrey J. Yuen, Ralph H. Raasch, Joseph J. Eron, David Martin, Patricia K. Mydlow and Elizabeth K. Hussey

    Version of Record online : 20 MAY 1996, DOI: 10.1016/S0009-9236(96)90183-6

  20. You have free access to this content
    Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B

    Hepatology

    Volume 51, Issue 2, February 2010, Pages: 415–421, Hyun Woong Lee, Heon Ju Lee, Jae Seok Hwang, Joo Hyun Sohn, Jae Young Jang, Ki Jun Han, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yong Han Paik, Chun Kyon Lee, Kwan Sik Lee, Chae Yoon Chon and Kwang-Hyub Han

    Version of Record online : 9 NOV 2009, DOI: 10.1002/hep.23323